Yao X, Liu Y, Luo Y, Liu X, et al. Safety and efficacy of the selective tyrosine kinase 2/Janus kinase 1 inhibitor TLL-018 in patients with moderate-to-severe chronic spontaneous urticaria with inadequate response to H1 antihistamines: a phase Ib, randomized, double-blind, placebo-cont Br J Dermatol 2026;195:222-231.
PMID: 41834239